EducationalSymposia-rp
Description
Room: 309 (Level 300)
ROLES OF BIOSIMILARS ON PATIENT ACCESS
Many studies demonstrate the clinical benefits of biologics in the early phases of autoimmune diseases. However, only a limited number of patients have access to the treatments due to their high-cost. The role of biosimilars is to make necessary biologic treatments more affordable and available to those needing treatment. We will discuss and compare the use of biosimilars in Europe and the US.

Moderator: HoUng Kim, MBA
Head of Strategy and Operation Divisions, Celltrion Healthcare, Incheon, Korea, Republic of (South)

Speaker: Edmund J. Pezalla, MD, PhD, MPH
Former President, Aetna, Wethersfield, CT, USA

Speaker: Jørgen Jahnsen, Ph.D
Professor, Gastroenterology, Akershus University Hospital, Lørenskog, Norway

Speaker: HoUng Kim, MBA
Head of Strategy and Operation Divisions, Celltrion Healthcare, Incheon, Korea, Republic of (South)

Speaker: Laszlo Gulacsi, Ph.D
Professor, Department of Health Economics, Corvinus University of Budapest, Budapest, Czech Republic

Celltrion Healthcare
(Sponsored by Celltrion Healthcare)
Tags